UFP Technologies(US:UFPT)2026-02-27 21:13Financial Performance - Net sales for the year ended December 31, 2025 increased 19.5% to $602.8 million from $504.4 million in 2024, driven by a 23.2% growth in sales to medical market customers [137]. - The companies acquired in 2024 and 2025 contributed approximately $168.3 million in sales for the year ended December 31, 2025, compared to $73.1 million in the same period last year [143]. - Gross profit margin decreased to 28.3% for the year ended December 31, 2025, down from 29.1% in 2024, primarily due to increased overhead and labor costs [144]. - Selling, General, and Administrative Expenses (SG&A) rose 24.5% to $77.4 million for the year ended December 31, 2025, with SG&A as a percentage of sales increasing to 12.8% [145]. - Net interest expense increased to approximately $9.8 million for the year ended December 31, 2025, up from $8.1 million in 2024, due to higher average debt levels [149]. - The effective tax rate for the year ended December 31, 2025 was 17.2%, a decrease from 19.2% in 2024, due to a favorable mix of pre-tax income [151]. - The AJR Labor Issue added over $6.3 million in incremental labor costs to the cost of sales for the year ended December 31, 2025 [138]. Cash Flow and Investments - Net cash provided by operations for the year ended December 31, 2025 was approximately $91.9 million, resulting from net income of approximately $68.3 million [155]. - Net cash used in investing activities was approximately $27.6 million, primarily for manufacturing machinery, equipment, and acquisitions [156]. - The company generated approximately $91.9 million in cash from operations for the year ended December 31, 2025 [164]. Debt and Liquidity - Outstanding borrowings under the Third Amended and Restated Credit Agreement were approximately $135.5 million as of December 31, 2025, with a weighted average interest rate of approximately 5.1% [161]. - Future maturities of long-term debt total $135.455 million, with $109.375 million due in 2026-2028 and $26.080 million in 2029 [163]. - The company’s liquidity is contingent upon future operating performance and the availability of draws on its revolving credit facility [164]. Future Outlook and Risks - The company plans to enhance manufacturing capacity and may consider acquisitions to support anticipated growth [165]. - Future capital requirements for expansions and acquisitions could be substantial, relying on existing resources and cash flow from operations [166]. - Economic uncertainties, including inflation and bank failures, could impact the company's long-term capital access [164]. - Market risk includes fluctuations in interest rates, with a weighted average interest rate of approximately 5.1% as of December 31, 2025 [171]. - Interest on credit facilities ranges from SOFR plus 1.25%-2.25% or the bank's prime rate plus 0.25%-1.25% [171]. Accounting and Tax Considerations - The enactment of the "One Big Beautiful Bill Act" (OBBBA) includes key tax provisions, but its impact on income tax expense is considered immaterial [167]. - The company evaluates critical accounting estimates based on historical experience and current economic conditions, which may affect reported financials [168].